Pharsight Monthly Summary
OCTOBER, 2023
Recent happenings in patent protected drugs.
spacer_11
At a Glance
28
drug patents lapsed
Photos
86
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
ABBVIE
 
AGIOS PHARMS INC
 
AMICUS THERAP US
 
ANTARES PHARMA INC
 
ARCUTIS
 
ASTRAZENECA
 
AVADEL CNS
 
AXSOME
 
AXSOME MALTA
 
AZURITY
 
BAUSCH
 
BEIGENE
 
BIOXCEL
 
BOEHRINGER INGELHEIM
 
DECIPHERA PHARMS
 
EAGLE PHARMS
 
EIRGEN
 
FABRE KRAMER
 
FERRING
 
INNOCOLL
 
JAZZ PHARMS RES
 
MALLINCKRODT IRELAND
 
MAYNE PHARMA
 
MYOVANT SCIENCES
 
NEURELIS INC
 
NOVO
 
PF PRISM CV
 
RADIUS
 
RVL PHARMS
 
SALIX PHARMS
 
SAPTALIS PHARMS
 
SCILEX PHARMS
 
SHORLA
 
STEMLINE THERAP
 
STERISCIENCE
 
SUMITOMO PHARMA
 
TOLMAR
 
UCB INC
 
UNITED THERAP
 
VANDA PHARMS INC
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE ALEXZA PHARMS
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ARNUITY ELLIPTA GLAXOSMITHKLINE
AXUMIN BLUE EARTH
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN NOVO
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
ORBACTIV MELINTA THERAP
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VENLAFAXINE BESYLATE ALMATICA
VIIBRYD ABBVIE
VYVANSE TAKEDA PHARMS USA
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
DEXILANT 8722084 Oct, 2023
DEXILANT 8784885 Oct, 2023
DEXILANT SOLUTAB 8784885 Oct, 2023
DUTREBIS 7169780 Oct, 2023
ELIGARD KIT 8470359 Oct, 2023
FENSOLVI KIT 8470359 Oct, 2023
FINACEA 10322085 Oct, 2023
FINACEA 8722021 Oct, 2023
FINACEA 8900554 Oct, 2023
INJECTAFER 10519252 Oct, 2023
INJECTAFER 11123321 Oct, 2023
INJECTAFER 11291645 Oct, 2023
INJECTAFER 11590097 Oct, 2023
INJECTAFER 9376505 Oct, 2023
ISENTRESS 7169780 Oct, 2023
ISENTRESS 7169780 Oct, 2023
ISENTRESS HD 7169780 Oct, 2023
LEVOXYL 7101569 Oct, 2023
ONZETRA XSAIL 8327844 Oct, 2023
ORAVERSE 7569230 Oct, 2023
REBETOL 6790837*PED Oct, 2023
RECLAST 8052987 Oct, 2023
REVLIMID 7468363 Oct, 2023
REVLIMID 7968569 Oct, 2023
REVLIMID 8492406 Oct, 2023
RYZOLT 7988998 Oct, 2023
VOTRIENT 7105530 Oct, 2023
XHANCE 8327844 Oct, 2023
Newly introduced Drug Patents
Drug Patent Patent expiry
AUVELITY 11779579 Nov, 2034
BOSULIF 11103497 Feb, 2034
BOSULIF 11103497*PED Aug, 2034
BOSULIF 7417148 Dec, 2025
BOSULIF 7417148*PED Jun, 2026
BOSULIF 7767678 Nov, 2026
BOSULIF 7767678*PED May, 2027
BOSULIF 7919625 Dec, 2025
BOSULIF 7919625*PED Jun, 2026
BOSULIF RE42376 Apr, 2024
BOSULIF RE42376*PED Oct, 2024
BRUKINSA 11786531 Jan, 2043
CABTREO 10220049 Jun, 2029
CABTREO 10624918 Jun, 2029
CABTREO 11389467 Dec, 2040
CABTREO 8288434 Aug, 2029
CABTREO 9561208 Jun, 2029
CALQUENCE 11771696 Jan, 2035
CALQUENCE 11771696 Jan, 2035
ELIGARD KIT 11771841 Dec, 2041
EPIDIOLEX 11766411 Jun, 2035
EXXUA 7538116 Sep, 2025
FENSOLVI KIT 11771841 Dec, 2041
FINTEPLA 11759440 Aug, 2037
FIRMAGON 11766468 Apr, 2032
FOCINVEZ 11065265 Jan, 2039
GALAFOLD 11786516 May, 2038
HETLIOZ 11759446 Feb, 2041
HETLIOZ 11760740 Feb, 2035
HETLIOZ LQ 11759446 Feb, 2041
HETLIOZ LQ 11760740 Feb, 2035
IGALMI 11786508 Dec, 2037
IGALMI 11806334 Jan, 2043
JYLAMVO 11771701 Oct, 2034
KONVOMEP 11771686 Mar, 2040
LIKMEZ 11541035 Oct, 2039
LUMRYZ 11779557 Mar, 2042
MYFEMBREE 11793812 May, 2038
MYFEMBREE 11795178 Sep, 2033
NEXTSTELLIS 11793760 Jun, 2036
OFEV 10105323*PED Dec, 2029
OFEV 10154990*PED Jul, 2026
OFEV 6762180*PED Apr, 2026
OFEV 9907756*PED Dec, 2029
OPFOLDA 10208299 Sep, 2035
OPFOLDA 10512677 Mar, 2033
OPFOLDA 10857212 Aug, 2037
OPFOLDA 10961522 Sep, 2035
OPFOLDA 11278599 Mar, 2033
OPFOLDA 11278601 Dec, 2036
OPFOLDA 11753632 Sep, 2035
ORGOVYX 11795178 Sep, 2033
ORSERDU 11779552 Oct, 2034
PEMFEXY 11793813 Feb, 2036
POSIMIR 11771624 Jan, 2041
PYRUKYND 11793806 Apr, 2033
QINLOCK 11779572 Oct, 2042
QINLOCK 11793795 Dec, 2040
RAYALDEE 11801253 Sep, 2030
REMODULIN 11723887 Dec, 2028
REMODULIN 7999007 Mar, 2029
REMODULIN 8653137 Sep, 2028
REMODULIN 8658694 Sep, 2028
REMODULIN 9199908 May, 2024
REMODULIN 9593066 Dec, 2028
REMODULIN 9604901 Dec, 2028
RINVOQ 11767326 Oct, 2036
RINVOQ 11773105 Oct, 2036
RINVOQ 11773106 Oct, 2036
RIVFLOZA 10351854 Oct, 2035
RIVFLOZA 10738311 Oct, 2035
RIVFLOZA 11053502 Oct, 2035
RIVFLOZA 11286488 Oct, 2038
RIVFLOZA 11359203 Oct, 2035
RIVFLOZA 11661604 Oct, 2038
SUNOSI 11779554 Dec, 2042
SUNOSI 11793776 Dec, 2042
TERLIVAZ 10335452 Apr, 2037
TYMLOS 11782041 Apr, 2038
UPNEEQ 11701343 Dec, 2039
VALTOCO 11793786 Mar, 2029
XIFAXAN 11779571 Feb, 2029
XYOSTED (AUTOINJECTOR) 11771646 Apr, 2034
ZORYVE 11793796 Jun, 2037
ZTLIDO 11786455 May, 2031
ZTLIDO 11793766 May, 2031
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2023 GreyB Research